ISSN: 2287-979X

Journal Home

Journal Guideline

Blood Research Q2 Unclaimed

Springer South Korea

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood Research is a journal indexed in SJR in Hematology with an H index of 33. It has an SJR impact factor of 0,609 and it has a best quartile of Q2. It has an SJR impact factor of 0,609.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,609

SJR Impact factor

33

H Index

62

Total Docs (Last Year)

210

Total Docs (3 years)

1732

Total Refs

374

Total Cites (3 years)

134

Citable Docs (3 years)

1.63

Cites/Doc (2 years)

27.94

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cytokine: X Q2
Cytokine Q2
Hematological Oncology Q2
Platelets Q2
Stem Cells and Development Q2

Compare this journals

Aims and Scope

Best articles by citations

Current status and future directions of clinical research and practice in adult acute lymphoblastic leukemia patients in Korea

Humanizing NOD/SCID/IL-2R gammanull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34+cells

Here comes the cord

Osteomalacia and myelofibrosis as a manifestation of vitamin D deficiency

Poor prognostic significance ofMycobacterium tuberculosisinfection during bortezomib-containing chemotherapy in patients with multiple myeloma

JAK2V617F-positive polycythemia vera accompanied by renal artery stenosis

Transplantation of human umbilical cord blood CD34+ cells into the liver of newborn NOD/SCID/IL-2R gamma null (NSG) mice after busulfan conditioning

Philadelphia-positive mixed phenotype acute leukemia presenting with PML-RARa fusion transcript without t(15;17) on cytogenetic studies

Pre- and post-therapy18F-FDG PET/CT of a patient affected by non-HIV multicentric IgG4-related Castleman disease

Hemophagocytic lymphohistiocytosis secondary to histoplasmosis

Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study

Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis

SHOW MORE ARTICLES

Hairy cell leukemia: a case report of atypical presentation without splenomegaly

Comparison of the characteristics of two hemoglobin variants, Hb D-Iran and Hb E, eluting in the Hb A2 window

Immune tolerance induction in patients with severe hemophilia A with inhibitors

Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients

Platelet-rich plasma: a healing virtuoso

The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer

Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients

Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature

Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience

Multiple myeloma in Korea: risk stratification and initial treatment

Expression ofSOCS1andSOCS3genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience